Understanding how RNA affects gene regulation in Fragile X syndrome
Elucidating the RNA-mediated mechanisms governing H3K9me3 deposition in fragile X syndrome
This study is looking at how RNA affects genes linked to Fragile X syndrome, which can cause developmental challenges, to help us understand the condition better and find new ways to improve treatments for those affected.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10912731 on NIH RePORTER |
What this research studies
This research investigates the role of RNA in the regulation of genes associated with Fragile X syndrome, a genetic condition that can cause developmental issues. The study focuses on how changes in the RNA from the FMR1 gene can lead to abnormal gene expression and contribute to the symptoms of the disorder. By examining the mechanisms that control the deposition of specific chemical markers on DNA, the research aims to uncover new insights into the disease's pathology. Patients may benefit from a better understanding of the underlying causes of their condition, which could lead to improved treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Fragile X syndrome or those carrying the premutation of the FMR1 gene.
Not a fit: Patients without a diagnosis of Fragile X syndrome or those not carrying the FMR1 gene mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide new insights into the mechanisms of Fragile X syndrome, potentially leading to more effective treatments.
How similar studies have performed: Previous research has shown promising results in understanding gene regulation mechanisms in similar genetic disorders, suggesting that this approach may yield valuable insights.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Malachowski, Thomas Ernst — University of Pennsylvania
- Study coordinator: Malachowski, Thomas Ernst
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.